Stock DAWN DAY ONE BIOPHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Day One Biopharmaceuticals, Inc.

Equities

DAWN

US23954D1090

Delayed Nasdaq
Other stock markets
 15:49:11 2024-05-20 EDT 		5-day change 1st Jan Change
15.97 USD -1.24% Intraday chart for Day One Biopharmaceuticals, Inc. -0.44% +9.45%
04:49pm BrightSpring Health Services Says Onco360 Selected as Pharmacy Partner for Ojemda MT
05-07 HC Wainwright Adjusts Price Target on Day One Biopharmaceuticals to $40 From $50, Maintains Buy Rating MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
DAY ONE BIOPHARMACEUTICALS, INC. Stock Day One Biopharmaceuticals, Inc.
 1.41B - - - - -
MODERNA, INC. Stock Moderna, Inc.
 50.93B -
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 42.12B
LONZA GROUP AG Stock Lonza Group AG
 42.05B
CELLTRION, INC. Stock Celltrion, Inc.
 29.18B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 26.02B
  1. Stock Market
  2. Equities
  3. DAWN Stock
  4. Charts Day One Biopharmaceuticals, Inc.
  5. Sector Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW